Los esteroides en polvo de China / GBL / Péptidos / HGH
bucky@pharm-chemicals.com +8613237122310
EnglishFrançaisDeutschLatīnaپارسیPortuguêsРусскийEspañolSvenskaTürkçe
 Editar Traducción

Otros esteroides

» Esteroides » Otros esteroides

Abiraterona CAS:154229-19-3

Abiraterone
Alias : 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol
CAS: 154229-19-3
Fórmula molecular: C24H31NO
Peso molecular: 349.51
Ensayo: 99%
Apariencia: polvo blanco
Grade: Grado farmacéutico
Almacenamiento: Shading, confined preservation

investigación
  • Presupuesto

Uso: It is indicated for use in combination with prednisone as a treatment for metastatic castration-resistant prostate cancer.

Abiraterone is a drug used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) — es decir., prostate cancer not responding to androgen deprivation or treatment with antiandrogens. It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. Cadila Pharmaceuticals has recently started marketing Abiraterone acetate under the trade name Abretone.

After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. In Phase III trials, it extended median survival to 14.8 months versus 10.9 months placebo, and the trial was stopped because of the successful outcome.

It is indicated for use in combination with prednisone as a treatment for metastatic castration-resistant prostate cancer. It has received FDA (28 April 2011), EMA (23 September 2011), MHRA (5 September 2011) and TGA (1 March 2012) approval for this indication. In Australia it is covered by the Pharmaceutical Benefits Scheme when being used to treat castration-resistant prostate cancer and given in combination with prednisone/prednisolone (subject to the conditions that the patient is not currently receiving chemotherapy, is either resistant or intolerant of docetaxel, has a WHO performance status of <2, and his disease has not since become progressive since treatment with PBS-subsidised abiraterone has commenced).

CATEGORÍA Y ETIQUETAS:
Otros esteroides , , , , , , , , , , , , , , , , ,

Formulario de Consulta ( vamos a ayudarle a volver tan pronto como sea posible )

Nombre:
*
Email:
*
Mensaje:

Verificación:
2 + 4 = ?

Tal vez como también

  • Nuestra ventaja

    Alta calidad

    Buen precio

    Entrega garantizada

    Mejor servicio

    100% Devolución de dinero

  • Productos principales

    GBL

    BDO

    Trembolona A / E

    Testosterona E / P

    HGH / HCG / IGF

  • Términos de pago

    Bitcoin

    Transferencia bancaria

    Western Union

    Money Gram

  • Contáctenos

    Email: bucky@pharm-chemicals.com

    WhatsApp: +8613237122310

    www.china-steroids-powder.com